Physician profile
Laina E Crowthers
NPI 1215953716
$4,037.67
in general payments reported to CMS, 2019-2025
26 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $69.25 · 2021: $228 · 2022: $155 · 2023: $2,263 · 2024: $693 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $597.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,630.65 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $148.05 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $137.18 | 2019-2024 | |
| Sage Therapeutics, LLC | $116.59 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $115.36 | 2021-2024 | Slynd |
| Merck Sharp & Dohme LLC | $114.27 | 2019-2024 | Gardasil, Gardasil 9 |
| Myovant Sciences INC. | $94.82 | 2021-2022 | |
| Hologic Sales and Service, LLC | $79.83 | 2021 | |
| Mylan Pharmaceuticals INC. | $69.40 | 2019-2022 | |
| Allergan, INC. | $68.36 | 2019-2020 | |
| Astellas Pharma US INC | $56.67 | 2019-2023 | Veozah |
| Coopersurgical, INC. | $54.58 | 2019-2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $49.21 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.15 | 2019 | |
| Exact Sciences Corporation | $36.13 | 2023 | Cologuard Collection Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $33.19 | 2019 | |
| Smith+Nephew, INC. | $26.43 | 2023 | Pico |
| Covidien Lp | $25.54 | 2019 | |
| Therapeuticsmd, INC. | $23.51 | 2022 | |
| Shield Therapeutics INC | $21.47 | 2024 | |
| Amag Pharmaceuticals, INC. | $17.77 | 2019 | |
| Lupin INC. | $16.80 | 2019 | |
| Organon LLC | $16.61 | 2022 | |
| Daiichi Sankyo INC. | $16.47 | 2023 | Injectafer |
| Boston Scientific Corporation | $14.85 | 2019 | |
| Avion Pharmaceuticals | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laina Crowthers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.